The Ledger / Rudolf Maag
Rudolf Maag
◼ Origin
Rudolf Maag is a Swiss deal-maker and life-sciences investor who built his fortune primarily through a ~15% stake in Synthes (medical devices and bone-fixation implants), acquired via orchestrating the 1999 merger of Stratec Medical with Synthes. That stake was realized when Johnson & Johnson acquired Synthes in 2012 for $20 billion. He also holds approximately 12% of Straumann Holdings, the world's leading dental implant manufacturer.
◼ Self-Made Verdict — YES
Built his fortune through his own capital allocation and deal-making in the life sciences sector — no inherited wealth base documented. Orchestrated the 1999 Synthes merger and acquired his stake through professional expertise, not inheritance.
◼ Documented marks
01
Swiss life-sciences investor; built fortune through ~15% stake in Synthes (bone fixation/medical devices), realized via J&J's $20B acquisition (2012)
02
Holds ~12% of Straumann Holdings (dental implants), world's leading dental implant manufacturer
03
Orchestrated the 1999 merger of Stratec Medical with Synthes to create the combined entity
04
Not connected to Syngenta or agrochemicals; wealth is entirely life sciences / medical devices
05
Net worth: ~$5.6–5.8B (2024–25 estimates)
No inheritance, or primary accounts documented for this billionaire yet.
◼ List of charges
Total sentence
0–0 years
That is
0.0–0.0 life sentences
(using 78 years as one life)
These are moral charges, not legal ones. The actual legal system has not — and will not — bring them.
More ledger entries